ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "risk assessment"

  • Abstract Number: 1151 • ACR Convergence 2024

    Clinical Characterization and Recurrence Prediction Model for Immune-Mediated Necrotizing Myopathy

    Beibei Cui1, Hongjiang Liu2, Geng Yin3 and Qibing Xie4, 1Rheumatology and Immunology, Chengdu, China (People's Republic), 2West China Hospital, Sichuan University, Chengdu, China (People's Republic), 3Department of Rheumatology and Immunology, chengdu, China (People's Republic), 4Department of Rheumatology and Immunology, Chengdu, Sichuan, China

    Background/Purpose: The primary objective of this study was to comprehensively analyze the clinical characteristics of immune-mediated necrotizing myopathy (IMNM) and develop a reliable recurrence prediction…
  • Abstract Number: 1918 • ACR Convergence 2024

    Exploring the Childhood Opportunity Index and Distance to Care in a Cohort of Children with Rheumatic Disease

    Kristina Ciaglia1 and Alaina Beauchamp2, 1UT Southwestern Medical Center and Scottish Rite for Children, Dallas, TX, 2UT Southwestern Medical Center, Dallas

    Background/Purpose: Children from disadvantaged neighborhoods and socioeconomic backgrounds experience worse outcomes and delays in care.¹ The Childhood Opportunity Index (COI) is a multidimensional validated tool…
  • Abstract Number: 0444 • ACR Convergence 2024

    Deep Serologic Profiling Identifies Novel Autoantibodies Associated with Fetal Atrioventricular Block

    Philip Carlucci1, Robert Clancy2, Mala Masson3, Colin Phoon4, Ashley Roman4, Peter Izmirly5, Amit Saxena6, H Michael Belmont4, Christina Penfield4, Young Mi Lee4, Julie Nusbaum7, Andrew Rubenstein4, Ruben Acherman8, Elena Sinkovskaya9, Alfred Abuhamad9, Karla Bermudez-Wagner9, Majd Makhoul10, Gary Satou11, Whitnee Hogan12, Nelangi Pinto13, Anita Moon-Grady14, Lisa Howley15, Mary Donofrio16, Anita Krishnan16, Jaclyn Phillips17, Stephanie Levasseur18, Miwa Geiger19, Erin Paul20, Sonal Owens21, Kristopher Cumbermack22, Jyothi Matta23, Gary Joffe24, Christopher Lindblade25, Carl Weiner26, Caitlin Haxel27, Katherine Kohari28, Joshua Copel28, James Strainic29, Tam Doan30, Shreya Sheth30, Stacy Killen31, Theresa Tacy32, Michelle Kaplinski32, Nicola Fraser4, Kelly Ruggles33, Bettina Cuneo34 and Jill Buyon35, 1New York University School of Medicine, New York, NY, 2Columbia University Medical Center, New York, NY, 3NYU Langone Medical Center- Division of Rheumatology, New York, NY, 4NYU Langone Health, New York, NY, 5New York University Grossman School of Medicine, New York, NY, 6NYU Grossman School of Medicine, New York, NY, 7NYU Langone Hospital - Long Island, Internal Medicine - Rheumatology, Mineola, NY, 8Children's Heart Center, Las Vegas, NV, 9Eastern Virginia Medical School, Norfolk, VA, 10Atrium Health Levine Children's Hospital, Charlotte, NC, 11University of California Los Angeles, Los Angeles, CA, 12University of Utah, Salt Lake City, UT, 13Seattle Children's Hospital, Seattle, WA, 14University of California San Francisco, San Francisco, CA, 15Midwest Fetal Care Center, Children's Minnesota/Allina Health, Minneapolis, MN, 16Children's National Hospital, Washington, DC, 17George Washington University, Washington, DC, 18Columbia University, New York, NY, 19Mount Sinai School of Medicine, New York, NY, 20Atlantic Health System, Morristown, NJ, 21University of Michigan, Ann Arbor, MI, 22University of Kentucky, Lexington, KY, 23University of Louisville, Louisville, KY, 24Perinatal Associates of New Mexico, Albuquerque, NM, 25Phoenix Children's Hospital, Phoenix, AZ, 26Dignity Health, Phoenix, AZ, 27University of Vermont Children's Hospital, Burlington, VT, 28Yale University, New Haven, CT, 29UH Rainbow Babies, Cleveland, OH, 30Baylor College of Medicine, Houston, TX, 31Vanderbilt University, Nashville, TN, 32Stanford University, Stanford, CA, 33NYU Grossman School of Medicine, Brooklyn, NY, 34University of Arizona College of Medicine, Tucson, AZ, 35New York University Grossman School of Medicine, New York, NY

    Background/Purpose: Maternal anti-SSA/Ro52/60kD autoantibodies are necessary for the development of fetal atrioventricular block (AVB) but titers alone are not sufficient to predict the likelihood of…
  • Abstract Number: 1192 • ACR Convergence 2024

    Relationship Between Measures of Fat Mass and Knee Osteoarthritis Incidence: The Multicenter Osteoarthritis (MOST) Study

    Kristine Godziuk1, Sarah Tilley2, mike LaValley3, Douglas Kiel4, Michael Nevitt5, C.E. Lewis6, James Torner7 and Tuhina Neogi2, 1University of Alberta, Edmonton, AB, Canada, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3Boston University School of Public Health, Arlington, MA, 4Hebrew SeniorLife and Department of Medicine Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, 5UCSF, Orinda, CA, 6University of Alabama at Birmingham, Birmingham, AL, 7University of Iowa, Iowa City

    Background/Purpose: Obesity [defined by body mass index (BMI) ≥30 kg/m2] is an established risk factor for incident radiographic knee OA (ROA). However, the relative contributions…
  • Abstract Number: 1956 • ACR Convergence 2024

    Artificial Intelligence Enhanced Analysis of Nailfold Capillaries by Dermatoscopy in Rheumatology Centers

    Genessis Maldonado1, Eduardo Ramos-ibañez2, Borja del Carmelo Gracia-Tello3, Radic Mislav4 and Tracy Frech1, 1Vanderbilt University Medical Center, Nashville, TN, 2University of Zaragoza, Zaragoza, Spain, 3Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain, 4University Hospital of Split, Split, Croatia

    Background/Purpose: The use of dermatoscopes in rheumatology has been established for several years. However, the application of artificial intelligence for the detection of abnormalities in…
  • Abstract Number: 0462 • ACR Convergence 2024

    Circulating Mediators of Endothelial Dysfunction as Predictors of Incident Heart Failure in Rheumatoid Arthritis

    Tate Johnson1, Michael Duryee1, Carlos Hunter1, Punyasha Roul2, Joshua Baker3, grant Cannon4, Beth Wallace5, Paul Monach6, Andreas Reimold7, Gail Kerr8, Isaac Smith9, John Richards10, Katherine Wysham11, Gary Kunkel12, Iris Lee13, Daniel Anderson14, Geoffrey Thiele1, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC, Omaha, NE, 3University of Pennsylvania, Philadelphia, PA, 4University of Utah and Salt Lake City VA, Salt Lake City, UT, 5Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 6VA Boston Healthcare System, Boston, MA, 7Dallas VA Medical Center, Dallas, TX, 8Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 9Duke University Hospital, Durham, NC, 10Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 11VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 12University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 13Washington University in St Louis, Saint Louis, MO, 14University of Nebraska Medical Center, Durham, NC

    Background/Purpose: Endothelial dysfunction, leading to myocardial inflammation and dysfunction, may drive a heightened risk of heart failure (HF) in people with rheumatoid arthritis (RA). Circulating…
  • Abstract Number: 1202 • ACR Convergence 2024

    Harnessing MicroRNA and Machine/Deep Learning for Early Prediction of Knee Osteoarthritis Structural Progression

    Afshin Jamshidi1, Osvaldo Espin-Garcia2, Thomas G. Wilson3, Ian Loveless3, Jean-Pierre Pelletier1, Amanda Ali4 and Johanne Martel-Pelletier1, 1Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 2Department of Epidemiology and Biostatistics, University of Western Ontario; Dalla Lana School of Public Health and Department of Statistical Sciences, University of Toronto; Department of Biostatistics, Schroeder Arthritis Institute; Krembil Research Institute, University Health Network, Toronto, ON, Canada, 3Henry Ford Health + Michigan State University Health Sciences, Detroit, MI, 4Henry Ford Health + Michigan State University Health Sciences; Center for Molecular Medicine and Genetics, Wayne State University, Montreal, QC, Canada

    Background/Purpose: The development of knee osteoarthritis (OA) is generally characterized by a slow evolution. However, its progression and severity may occur rapidly in some individuals.…
  • Abstract Number: 2018 • ACR Convergence 2024

    Non-adherence to Urate Lowering Therapy in Gout After 5 Years Is Related to Poor Outcomes – Results from the NOR-Gout Study

    Tillmann Uhlig1, Lars F Karoliussen1, Joseph Sexton2, Sella A. Provan2, Espen A. Haavardsholm3, Nicola Dalbeth4 and Hilde B Hammer1, 1Diakonhjemmet Hospital, Oslo, Norway, 2Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, Oslo, Norway, 3Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, and University of Oslo (UiO), Institute of Clinical Medicine, Oslo, Norway, Oslo, Norway, 4University of Auckland, Auckland, New Zealand

    Background/Purpose: People with gout need to adhere to medication over time to achieve good outcomes. We assessed self-reported adherence to medication with urate lowering therapy…
  • Abstract Number: 0637 • ACR Convergence 2023

    Comparison of Four Risk Stratification Models for Prediction of Mortality in Systemic Sclerosis-associated Pulmonary Arterial Hypertension in the EUSTAR Cohort

    Hilde Jenssen Bjørkekjær1, Cosimo Bruni2, Cathrine Brunborg3, Patricia Carreira4, Paolo Airò5, Carmen Pilar Simeon-Aznar6, Marie-Elise Truchetet7, Alessandro Giollo8, Alexandra Balbir-Gurman9, Mickael Martin10, Christopher Denton11, Armando Gabrielli12, Havard Fretheim13, Imon Barua13, Helle Bitter14, Oyvind Midtvedt13, Torhild Garen15, Kaspar Broch16, Arne Andreassen17, Yoshiya Tanaka18, Gabriela Riemekasten19, Ulf Müller-Ladner20, marco Matucci Cerinic21, Ivan Castellvi22, Elise Siegert23, Eric Hachulla24, Oliver Distler2 and Anna-Maria Hoffmann-Vold13, 1Department of Rheumatology, Hospital of Southern Norway, Kristiansand & University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 2Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 3Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital - Rikshospitalet, Oslo, Norway, 4Hospital Universitario 12 de Octubre, Madrid, Spain, 5Spedali Civili di Brescia, Scleroderma UNIT, UOC Reumatologia ed Immunologia Clinica, Piazzale Spedali Civili 1, 25123, Brescia, Italy, 6Department of Internal Medicine, Systemic Autoimmune Diseases Unit, Hospital Universitario Vall d'Hebronh, Barcelona, Spain, 7Bordeaux University Hospital, Bordeaux, France, 8University of Verona, Rheumatology Section, Department of Medicine, Verona, Italy, Verona, Italy, 9Rheumatology Institute, Rambam Health Care Campus and Rappaport Faculty of |Medicine, Technion, Haifa, Israel, 10Department of Internal Medicine, INSERM U1313, Poitiers University, Poitiers University Hospital, Poitiers, France, 11University College London, London, United Kingdom, 12Ospedali Riuniti Marche, Ancona, Italy, 13Oslo University Hospital, Oslo, Norway, 14Sorlandet sykehus, Kristiansand, Norway, 15Dept of Rheumatology, University Hospital Oslo, Oslo, Norway, 16Oslo University Hospital, Rikshospitalet, Department of Cardiology, Oslo, Norway, KG Jebsen center, Institute for Experimental Medical Research, University of Oslo, Oslo, Norway, 17Oslo University Hospital, Rikshospitalet, Department of Cardiology, Oslo, Norway, 18University of Occupational and Environmental Health, Kitakyushu, Japan, 19University Clinic Schleswit-Holstein (UKSH), Lübeck, Germany, 20Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, 21Unit of Immunology, Rheumatology, Allergy and Rare diseases, IRCCS San Raffaele Hospital, Milan, Milan, Italy, 22Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Sant Just Desvern, Spain, 23Department of Rheumatology, Charité University Hospital, Charité Platz 1, D-10117, Berlin, Germany, 24University of Lille, Lille, France

    Background/Purpose: The 2022 ESC/ERS Guidelines recommend comprehensive risk stratification at diagnosis of pulmonary arterial hypertension (PAH) to guide optimized management.1Several risk stratification tools have been…
  • Abstract Number: 2267 • ACR Convergence 2023

    Explainable Machine Learning to Predict Hospitalized Infection in Patients with Systemic Lupus Erythematosus

    Hsin-Hua Chen1 and Wen-Nan Huang2, 1Taichung Veterans General Hospital, Taichung, Taiwan, 2Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Veterans General Hospital, College of Medicine National Chung Hsing University, Department of Business Administration, Ling-Tung University, Taichung, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have a 1.85-fold higher risk of all-cause mortality and a 2.74 fold higher risk of infection-related mortality compared…
  • Abstract Number: 0638 • ACR Convergence 2023

    Application of the 2022 European Society of Cardiology (ESC) Risk Assessment Model in Australian and Singaporean Systemic Sclerosis Patients with Newly Diagnosed Pulmonary Arterial Hypertension (PAH)

    Zoe Brown1, Dylan Hansen2, Wendy Stevens3, Nava Ferdowsi4, laura ross5, Alannah Quinlivan6, Joanne Sahhar7, Gene-Siew Ngian7, Diane Apostolopoulos7, Jennifer G Walker8, Susanna Proudman9, Gim Gee Teng10, Andrea Hsiu Ling Low11, Kathleen Morrisroe12 and Mandana Nikpour13, 1The University of Melbourne, Armadale, Australia, 2Department of Rheumatology, St Vincent’s Hospital Melbourne, Fitzroy, Australia, 3Department of Rheumatology, St Vincent's Hospital Melbourne, Fitzroy, Australia, 4St Vincents Hospital, Kew, Australia, 5St. Vincent's Hospital Melbourne, Fitzroy, Australia, 6St Vincent's Hospital Melbourne, Highett, Australia, 7Monash Health and Monash University, Clayton, Australia, 8Royal Adelaide Hospital, Adelaide, Australia, 9Royal Adelaide Hospital and University of Adelaide, Adelaide, Australia, 10Alexandra Hospital, Department of Medicine, Division of Rheumatology, National University Health System, Singapore, Singapore, 11Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore, 12The University of Melbourne at St Vincent’s Hospital Melbourne, Fitzroy, Australia, 13The University of Melbourne at St. Vincent’s Hospital Melbourne, Departments of Medicine and Rheumatology, Melbourne, Australia

    Background/Purpose: Pulmonary arterial hypertension (PAH) patients can be stratified as low, intermediate, or high risk of 1-year mortality based on clinical, biochemical and haemodynamic prognostic…
  • Abstract Number: 2323 • ACR Convergence 2023

    An Electronic Health Record-Based Algorithm for Predicting Systemic Lupus Erythematosus Flares: Integrating Clinical Factors and Social Determinants of Health

    Yu Huang1, Lixia Yao2, zhengkang Fan3, Jingchuan Guo1 and Jiang Bian1, 1University of Florida, Gainesville, FL, 2Polygon Health Analytics LLC, Chalfont, PA, 3University of Florida, Gainsville, FL

    Background/Purpose: Systemic lupus erythematosus (SLE) has a relapsing-remitting course, with patients experiencing disease activity flares over time. Flares and prolonged disease activity are associated with…
  • Abstract Number: 0654 • ACR Convergence 2023

    Comparison of Cardiovascular Risk in Patients with Systemic Sclerosis and the General Population

    Sabina Oreska1, Hana Storkanova1, Jaroslav Kudlicka2, Vladimir Tuka2, Ondrej Mikes2, Zdislava Krupickova2, Martin Satny2, Eva Chytilova2, Jan Kvasnicka2, Maja Spiritovic3, Barbora Hermankova4, Petr Cesak5, Marian Rybar6, Karel Pavelka7, Ladislav Senolt8, Radim Becvar9, Jiri Vencovsky1, Michal Vrablik2 and Michal Tomcik1, 1Institute of Rheumatology, Prague, Czech Republic, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 23rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 3Institute of Rheumatology, Prague, Czech Republic, Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, 4Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, 5Department of Human Movement Laboratory, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, 6Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic, 7Institut of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Praha, Czech Republic, 8Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Praha, Czech Republic, 9Institute of Rheumatology, Prague, Czech Republic, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Praha, Czech Republic

    Background/Purpose: Patients with systemic sclerosis (SSc) may be burdened by increased cardiovascular (CV) risk due to accelerated atherosclerosis (ATS) due to systemic inflammation, and vascular…
  • Abstract Number: 2362 • ACR Convergence 2023

    Identification of Protein Biomarkers Associated with the Severity and Risk of Progression of Interstitial Lung Disease in VEDOSS and Established Systemic Sclerosis Patients

    Thierry Sornasse1, Vishal Kakkar2, Rebecca Ross3, Sunhwa Kim4 and Francesco Del Galdo5, 1AbbVie, Inc., North Chicago, IL, 2University of Leeds, Leeds, United Kingdom, 3Medicine and Health, University of Leeds, Leeds, United Kingdom, 4AbbVie, Inc., South San Francisco, CA, 5University of Leeds - Leeds Institute of Rheumatic and Muskuloskeletal Medicine, Leeds, United Kingdom

    Background/Purpose: Pulmonary Fibrosis (PF) is one of the primary causes of systemic sclerosis (SSc)-related death. Hence, monitoring and predicting the course of PF in SSc…
  • Abstract Number: 0015 • ACR Convergence 2023

    Genetic Predisposition to a Positive Antinuclear Antibody Test Is Not Associated with Increased Risk of Disease

    Gul Karakoc1, Ge Liu1, Jacy Zanussi2, Cecilia Chung2, Jorge Gamboa1, Jonathan Mosley1, Nancy Cox1, C. Michael Stein1 and Vivian Kawai1, 1Vanderbilt University Medical Center, Nashville, TN, 2University of Miami, Miami, FL

    Background/Purpose: Antinuclear antibodies (ANA) are biomarkers that are frequently used in the diagnosis of common autoimmune (AI) disorders, but are also present in ~12-20% of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology